iPSC-Derived GABAergic Neurons

iPSC-Derived GABAergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived GABAergic Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Stem Cell-Derived Neurons</td>
</tr>
<tr>
<td class="label">Origin</td>
<td>Induced Pluripotent Stem Cells</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (Gamma-Aminobutyric Acid)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>GAD1, GAD2, DLX2, VGAT, PARVALBUMIN, SOMATOSTATIN</td>
</tr>
<tr>
<td class="label"> subtypes</td>
<td>Parvalbumin+, Somatostatin+, Calretinin+, Reelin+</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Epilepsy, Alzheimer's Disease, Schizophrenia, Anxiety Disorders</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Function</td>
</tr>
<tr>
<td class="label">PV</td>
<td>Fast-spiking</td>
</tr>
<tr>
<td class="label">SST</td>
<td>Dendritic inhibition</td

iPSC-Derived GABAergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived GABAergic Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Stem Cell-Derived Neurons</td>
</tr>
<tr>
<td class="label">Origin</td>
<td>Induced Pluripotent Stem Cells</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (Gamma-Aminobutyric Acid)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>GAD1, GAD2, DLX2, VGAT, PARVALBUMIN, SOMATOSTATIN</td>
</tr>
<tr>
<td class="label"> subtypes</td>
<td>Parvalbumin+, Somatostatin+, Calretinin+, Reelin+</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Epilepsy, Alzheimer's Disease, Schizophrenia, Anxiety Disorders</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Function</td>
</tr>
<tr>
<td class="label">PV</td>
<td>Fast-spiking</td>
</tr>
<tr>
<td class="label">SST</td>
<td>Dendritic inhibition</td>
</tr>
<tr>
<td class="label">CR</td>
<td>Modulatory</td>
</tr>
<tr>
<td class="label">VIP</td>
<td>Disinhibition</td>
</tr>
</table>

Ipsc Derived Gabaergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Induced pluripotent stem cell (iPSC)-derived GABAergic neurons are inhibitory neurons that produce gamma-aminobutyric acid (GABA) as their primary neurotransmitter. Generated from patient-specific or healthy donor-derived iPSCs, these neurons provide powerful models for studying epilepsy, Alzheimer's disease, psychiatric disorders, and for developing GABAergic cell replacement therapies["@maroof2013"][@nicholas2013].

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: GABAergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
• [OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
• [OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Differentiation Protocols

Overview

Generating GABAergic neurons from iPSCs involves directing differentiation toward telencephalic fate, specifically the medial ganglionic eminence (MGE), which gives rise to cortical inhibitory neurons.

Key Steps

Signaling Molecules

• SHH (Sonic Hedgehog): Ventral patterning
• FGF2: Proliferation and survival
• WNT inhibitors: Promote cortical inhibitory fate
• BDNF: Neuronal maturation
• GDNF: GABAergic neuron survival
• cAMP: Enhance GABA production

GABAergic Neuron Subtypes

Parvalbumin (PV) Neurons

• Fast-spiking interneurons
• Perisomatic inhibition
• Critical for gamma oscillations
• Affected in schizophrenia

Somatostatin (SST) Neurons

• Dendrite-targeting interneurons
• Regulate dendritic integration
• Reduced in Alzheimer's disease
• Important for memory circuits

Calretinin (CR) Neurons

• Inter laminar connectivity
• Modulatory functions
• Developmental studies

Reelin+ Neurons

• Layer 1 interneurons
• Cortical circuit development
• Migration studies

Molecular Characterization

GABA Synthesis Enzymes

• GAD1 (Glutamic Acid Decarboxylase 1): 67kDa isoform
• GAD2 (Glutamic Acid Decarboxylase 2): 65kDa isoform
• Both convert glutamate to GABA

Markers

• DLX2/DLX5: Transcription factors for GABAergic fate
• VGAT (Vesicular GABA Transporter): GABA packaging
• Gephyrin: Postsynaptic scaffolding
• GABAA Receptor subunits: Synaptic localization

Disease Modeling Applications

Epilepsy

iPSC-derived GABAergic neurons model epileptogenesis:

• Hyperexcitability: Understanding network dysfunction
• GABAergic dysfunction: How inhibition fails
• Drug screening: Anti-seizure compound testing
• Patient-specific models: Genetic epilepsy syndromes

Alzheimer's Disease

GABAergic dysfunction in AD:

• Somatostatin neurons: Reduced in AD hippocampus
• Network oscillations: Gamma rhythm disruption
• Memory circuits: Inhibition critical for encoding
• Therapeutic targets: Enhancing GABAergic function

Schizophrenia

GABAergic deficits in SZ:

• PV neuron dysfunction: Correlates with cognitive deficits
• Parvalbumin reduction: Postmortem brain studies
• GABA synthesis: GAD1/2 expression changes
• Drug development: Targeting GABAergic system

Anxiety Disorders

• GABAergic system: Primary therapeutic target
• Patient iPSC models: Understanding anxiety mechanisms
• SSRI effects: How antidepressants work
• Circuit dysfunction: Amygdala connectivity

Drug Screening Platforms

Anti-Seizure Drug Discovery

GABAergic neurons enable:

• GABA-A modulators: Enhancers of inhibition
• Sodium channel blockers: Reduce excitability
• Novel mechanisms: Target-specific compounds
• Patient-specific response: Predict efficacy

Psychiatric Drug Development

• Anxiolytics: GABA-A modulating compounds
• Antipsychotics: Effects on GABAergic transmission
• Cognitive enhancers: PV neuron function
• Depression treatments: GABA system modulation

Clinical Applications

Cell Therapy

Transplantation of GABAergic neurons:

• Temporal lobe epilepsy: Suppress seizures
• Trauma: Replace lost inhibitory neurons
• Stroke: Restore lost function
• DBS enhancement: Combine with stimulation

Challenges

• Subtype specification: Achieving specific subtypes
• Integration: Proper circuit incorporation
• Survival: Maintaining transplanted cells
• Function: Ensuring proper inhibition

Comparative Analysis

vs. Glutamatergic Neurons

• Opposing functions (inhibition vs. excitation)
• Different marker expression
• Distinct disease relevance
• Complementary research value

Interneuron Subtypes

Future Directions

Research Priorities

• 3D cultures: Organoids with inhibitory neurons
• Circuit modeling: Recreate cortical microcircuits
• Gene therapy: Direct conversion to GABAergic
• Biomarkers: Patient stratification

Emerging Technologies

• CRISPR: Genetic correction in patient iPSCs
• Optogenetics: Light-controlled GABAergic neurons
• Biosensors: Real-time GABA release
• Automated differentiation: Scale-up protocols

Background

The study of Ipsc Derived Gabaergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Epilepsy Foundation](https://www.epilepsy.com/) - Epilepsy research and resources](/resources)
• [Alzheimer's Association](https://www.alz.org/) - AD research and patient support
• [Brain & Behavior Research Foundation](https://bbrfoundation.org/) - Psychiatric disorder research

Pathway Diagram

The following diagram shows the key molecular relationships involving iPSC-Derived GABAergic Neurons discovered through SciDEX knowledge graph analysis: